HIGHLIGHTS
- who: AIM et al. from the University of Huddersfield, United Kingdom have published the paper: Myricitrin inhibits broblast-like synoviocyte-mediated rheumatoid synovial in fl ammation and joint destruction by targeting AIM2, in the Journal: (JOURNAL)
- what: The medical Ethical Committee of the First Affiliated Hospital at Sun Yat-sen University approved this study protocol (No 049), which was conducted in accordance with the recommendations of the Declaration of Helsinki. The authors focused on AMI2, the secondranked gene among the downregulated genes, with Myr treatment. The study show that Myr treatment ameliorated inflammatory responses and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.